Literature DB >> 29103205

Diagnostic dilemmas in chronic inflammatory bowel disease.

Maurice B Loughrey1, Neil A Shepherd2.   

Abstract

Histopathological assessment of biopsy and resection specimens of chronic inflammatory bowel disease (CIBD), or possible CIBD, forms a significant component of the routine workload in most tissue pathology laboratories. In this review, we have chosen selected areas of particular diagnostic difficulty in CIBD pathology, providing key advice for pathology reporting. Those mimics of CIBD which have the greatest potential for misdiagnosis are discussed, particularly the wide range of infectious colitides which represent possible diagnostic pitfalls. The most important distinguishing features between the two main forms of CIBD, ulcerative colitis and Crohn's disease, are addressed, first in relation to resection specimens, and then with emphasis on features which may also be diagnostically useful in endoscopic biopsy material. The importance of assessment of the index endoscopic specimen is stressed, before treatment has been instigated, along with careful correlation with clinical and endoscopic features. Problems in the assessment of post-surgical CIBD specimens are described and then the role of upper gastrointestinal pathology specimens in diagnosing both Crohn's disease and ulcerative colitis, with increased recognition of upper gastrointestinal tract involvement in the latter condition. Finally, with recent developments in endoscopic surveillance techniques and local excision options, modern approaches to reporting and managing neoplasia complicating CIBD are reviewed.

Entities:  

Keywords:  Biopsy pathology; Crohn’s disease; Diverticular colitis; Dysplasia; Infective colitis; Inflammatory bowel disease; Ulcerative colitis

Mesh:

Year:  2017        PMID: 29103205     DOI: 10.1007/s00428-017-2235-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  70 in total

1.  The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study.

Authors:  L W Lamps; K T Madhusudhan; J K Greenson; R H Pierce; N A Massoll; M C Chiles; P J Dean; M A Scott
Journal:  Am J Surg Pathol       Date:  2001-04       Impact factor: 6.394

2.  Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines.

Authors:  Roger M Feakins
Journal:  J Clin Pathol       Date:  2013-09-02       Impact factor: 3.411

3.  Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease.

Authors:  G Oberhuber; A Püspök; C Oesterreicher; G Novacek; C Zauner; M Burghuber; H Vogelsang; R Pötzi; M Stolte; F Wrba
Journal:  Gastroenterology       Date:  1997-03       Impact factor: 22.682

Review 4.  Update on infectious enterocolitides and the diseases that they mimic.

Authors:  Laura W Lamps
Journal:  Histopathology       Date:  2015-01       Impact factor: 5.087

5.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

6.  Patchy cecal inflammation associated with distal ulcerative colitis: a prospective endoscopic study.

Authors:  G D'Haens; K Geboes; M Peeters; F Baert; N Ectors; P Rutgeerts
Journal:  Am J Gastroenterol       Date:  1997-08       Impact factor: 10.864

7.  Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis.

Authors:  R Odze; D Antonioli; M Peppercorn; H Goldman
Journal:  Am J Surg Pathol       Date:  1993-09       Impact factor: 6.394

8.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

9.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

10.  Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study.

Authors:  Roopali Bansal Gupta; Noam Harpaz; Steven Itzkowitz; Sabera Hossain; Sierra Matula; Asher Kornbluth; Carol Bodian; Thomas Ullman
Journal:  Gastroenterology       Date:  2007-08-02       Impact factor: 22.682

View more
  2 in total

Review 1.  Histopathology of Non-IBD Colitis. A practical approach from the Italian Group for the study of the gastrointestinal tract (GIPAD).

Authors:  Vincenzo Villanacci; Luca Reggiani-Bonetti; Giuseppe Leoncini; Paola Parente; Moris Cadei; Luca Albarello; Giulio Mandelli; Alessandro Caputo
Journal:  Pathologica       Date:  2021-02

Review 2.  Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.

Authors:  Bence Kővári; Rish K Pai
Journal:  Adv Anat Pathol       Date:  2022-01-01       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.